Cases & Deals

  • Home
  • Practices
  • TxCell completes IPO on regulated market of Euronext in Paris

Share

TxCell completes IPO on regulated market of Euronext in Paris

April 2014

Client(s) TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, in connection with its €16.2 million (US$22.4 million) initial public offering of Ordinary Shares on the regulated market of Euronext in Paris. Oddo & Cie and Société Générale acted as joint book-running managers.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.